Enalapril/nitrendipine - AbbVie
Alternative Names: Eneas; Nitrendipine/enalaprilLatest Information Update: 18 May 2020
At a glance
- Originator Vita
- Class Antihypertensives; Dihydropyridines; Dipeptides; Small molecules
- Mechanism of Action ACE inhibitors; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Essential hypertension
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 03 Apr 2019 Chemical structure information added
- 01 Oct 2013 Warner Chilcott has been acquired and merged into Actavis Inc